Trends in breast cancer incidence among women with type-2 diabetes in British general practice

Onitilo, 2012, Diabetes and cancer II: role of diabetes medications and influence of shared risk factors, Cancer Causes Control, 23, 991, 10.1007/s10552-012-9971-4 Diabetes Atlas Internal Diabetes Federation, 7th ed., 2015. Forouzanfar, 2011, Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis, Lancet (London, England), 378, 1461, 10.1016/S0140-6736(11)61351-2 GLOBOCAN, 2012 Breast cancer incidence statistics, 2017 Diabetes Atlas Internal Diabetes Federation, 6th ed., 2013. 2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants, Lancet (London, England), 387, 1513, 10.1016/S0140-6736(16)00618-8 de Sousa-Uva, 2016, Trends in diabetes incidence from 1992 to 2015 and projections for 2024: a Portuguese General Practitioner’s Network study, Prim. Care Diabetes, 10, 329, 10.1016/j.pcd.2016.05.003 Hippisley-Cox, 2007 Starup-Linde, 2013, CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants—a systematic review and a meta-analysis, Curr. Drug Saf., 8, 296, 10.2174/15748863113086660071 Larsson, 2007, Diabetes mellitus and risk of breast cancer: a meta-analysis, Int. J. Cancer, 121, 856, 10.1002/ijc.22717 Xue, 2007, Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence, Am. J. Clin. Nutr., 86, s823, 10.1093/ajcn/86.3.823S Liao, 2011, Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature, Asian Pac. J. Cancer Prev., 12, 1061 Peairs, 2011, Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis, J. Clin. Oncol., 29, 40, 10.1200/JCO.2009.27.3011 World Health Organisation, 1994 Rose, 2012, The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression, Endocr. Relat. Cancer, 19, R225, 10.1530/ERC-12-0203 Cheraghi, 2012, Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis, PLoS One, 7, e51446, 10.1371/journal.pone.0051446 Herrett, 2015, Data resource profile: Clinical Practice Research Datalink (CPRD), Int. J. Epidemiol., 44, 827, 10.1093/ije/dyv098 Campbell, 2013, Is the CPRD GOLD population comparable to the U.K. population?, 29th ICPE Pharmacoepidemiology and Drug Savety Herrett, 2010, Validation and validity of diagnoses in the General Practice Research Database: a systematic review, Br. J. Clin. Pharmacol., 69, 4, 10.1111/j.1365-2125.2009.03537.x Khan, 2010, Validity of diagnostic coding within the General Practice Research Database: a systematic review, Br. J. Gen. Practice, 60, e128, 10.3399/bjgp10X483562 Levesque, 2010, Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes, BMJ, 340, b5087, 10.1136/bmj.b5087 Boggon, 2013, Cancer recording and mortality in the General Practice Research Database and linked cancer registries, Pharmacoepidemiol. Drug Saf., 22, 168, 10.1002/pds.3374 European Standard Population, 2017 Rothman, 1979 P. Boyle, D.M. Parkin, Chapter 11. Statistical Methods for Registries, in: International Agency for Research on Cancer, pp. 135–136 (age-standardized rate), 138–139 (age-standardized rate ratio). Harding, 2015, Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation, Diabetes Care, 38, 734, 10.2337/dc14-1996 Junod, 2011, An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts, BMC Cancer, 11, 401, 10.1186/1471-2407-11-401 Independent UK Panel on Breast Cancer Screening, 2012, The benefits and harms of breast cancer screening: an independent review, Lancet (London, England), 380, 1778, 10.1016/S0140-6736(12)61611-0 Hellmann, 2015, Body mass index and participation in organized mammographic screening: a prospective cohort study, BMC Cancer, 15, 294, 10.1186/s12885-015-1296-8 J.B. Austoker V., A. Berrington, R.G. Blanks, N.E. Day, T.J. Day, I.O. Ellis, Screening for breast cancer in England: past and future, NHSBSP Publication, 61 (2006). Bronsveld, 2015, Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence, Breast Cancer Res., 17 Gandini, 2014, Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders, Cancer Prev. Res. (Phila. PA), 7, 867, 10.1158/1940-6207.CAPR-13-0424 KWF kanker bestrijding, Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. Data from IKZ and RIVM, (2004) 218. 2017 2017